In renal cell cancer, higher levels of ELOVL5 correlate with poor clinical prognosis, and ELOVL5 seems to lead to cancer cell proliferation and invasion (Nitta et al. 2022). Here, ELOVL5 is linked to renal cell adenocarcinoma.